FDA Approves Zanvastro as First Alexander Disease Drug
Silver Spring, Maryland, USA, September 3, 2026 The U.S. Food and Drug Administration (FDA) has approved Zanvastro (zilganersen) injection...
Cipla
Advertisement
Cipla Partners with Qilu on Keytruda Biosimilar
Mumbai, India and Warren, New Jersey, USA, September 3, 2026 Cipla Limited, through its wholly owned subsidiary InvaGen Pharmaceuticals...
Cipla Strengthens Global Pharma Leadership and Access
MUMBAI, India, April 24, 2026 Cipla Limited continues to reinforce its position as a leading global pharmaceutical company, advancing...
Cipla Wins FDA Approval for IPF Drug Nintedanib
MUMBAI, India and WARREN, N.J., April 3, 2026 Cipla USA Inc., a subsidiary of Cipla Limited, has received final...
Cipla Launches Generic Liraglutide in US
MUMBAI, India & WARREN, N.J., USA – February 27, 2026 Cipla Limited announced the U.S. launch of Liraglutide Injection...
Advertisement
